The current valuation score of ImmuCell Corp is 9.04, ranking 54 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -166.77, which is -120.31% below the recent high of 33.88 and -6.90% above the recent low of -178.28.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.